Back to Search Start Over

Do Patients With Acute Heart Failure and Preserved Ejection Fraction Have Heart Failure at Follow-Up: Implications of the Framingham Criteria

Authors :
Lars Lund
Camilla Hage
U. Lofstrom
Jean-Claude Daubert
Cecilia Linde
Agnieszka Kapłon-Cieślicka
Emmanuel Oger
Erwan Donal
Karolinska Institutet [Stockholm]
CIC-IT Rennes
Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM)
CHU Pontchaillou [Rennes]
Centre d'Investigation Clinique [Rennes] (CIC)
Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM)
Medical University of Warsaw - Poland
MedtronicMedtronic
St. Jude MedicalSt. Jude Medical
Jonchère, Laurent
Université de Rennes 1 (UR1)
Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM)
Source :
Journal of Cardiac Failure, Journal of Cardiac Failure, 2020, 26 (8), pp.673-684. ⟨10.1016/j.cardfail.2019.04.013⟩, Journal of Cardiac Failure, Elsevier, 2020, 26 (8), pp.673-684. ⟨10.1016/j.cardfail.2019.04.013⟩
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Abstract

International audience; Background - Heart failure (HF) with preserved ejection fraction (HFpEF) may be misdiagnosed. We assessed prevalence and consistency of Framingham criteria signs and symptoms in acute vs subsequent stable HFpEF. Methods - Three hundred ninety-nine patients with acute HFpEF according to Framingham criteria were re-assessed in stable condition. Four definitions of HFpEF at follow-up: (1) Framingham criteria alone, (2) Framingham criteria and natriuretic peptides (NPs), (3) Framingham criteria, NPs, and European Society of Cardiology HF guidelines echocardiographic criteria, (4) Framingham criteria, NPs, and the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction (PARAGON) trial echocardiographic criteria. Results - At follow-up, HFpEF was still present in 27%, 22%, 21%, and 22%, respectively. Most prevalent in acute HFpEF were dyspnea at exertion (90%), pulmonary rales (71%), persisting at follow-up in 70% and 13%, respectively. Characteristics at acute HF with greater or lesser odds of stable HFpEF; (1) jugular venous distention (odds ratio [OR] 1.80, 95% confidence interval [CI] 1.13-2.87; P = .013) and pleural effusion (OR 0.45, 95% CI 0.24-0.85; P = .014) and (4), older age (1.04, 95% CI 1.01-1.08; P = .014) and tachycardia (>100 bpm) 0.52, 95% CI 0.27-1.00; P = .048). Conclusions - In patients with acute HFpEF, one-quarter met the HF definition according to Framingham criteria at ambulatory follow-up. The proportion of patients with postdischarge HFpEF was largely unaffected by additional echocardiographic or NP criteria Older age and jugular venous distention at acute presentation predicted persistent HFpEF at follow-up, whereas pleural effusion and tachycardia may yield false HFpEF diagnoses. This finding has implications for HFpEF trial design.

Details

ISSN :
10719164
Volume :
26
Database :
OpenAIRE
Journal :
Journal of Cardiac Failure
Accession number :
edsair.doi.dedup.....1642abcc7b0593b50b7eff3388837816